5ohj: Difference between revisions
Jump to navigation
Jump to search
m Protected "5ohj" [edit=sysop:move=sysop] |
No edit summary |
||
(4 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
==Human phosphodiesterase 4B catalytic domain in complex with a pyrrolidinyl inhibitor.== | |||
<StructureSection load='5ohj' size='340' side='right'caption='[[5ohj]], [[Resolution|resolution]] 1.60Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[5ohj]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5OHJ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5OHJ FirstGlance]. <br> | |||
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.6Å</td></tr> | |||
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=9VE:[(1~{S})-2-[3,5-bis(chloranyl)-1-oxidanyl-pyridin-1-ium-4-yl]-1-[4-[bis(fluoranyl)methoxy]-3-(cyclopropylmethoxy)phenyl]ethyl]+(2~{S})-1-[3-(dimethylcarbamoyl)phenyl]sulfonylpyrrolidine-2-carboxylate'>9VE</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5ohj FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5ohj OCA], [https://pdbe.org/5ohj PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5ohj RCSB], [https://www.ebi.ac.uk/pdbsum/5ohj PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5ohj ProSAT]</span></td></tr> | |||
</table> | |||
== Function == | |||
[https://www.uniprot.org/uniprot/PDE4B_HUMAN PDE4B_HUMAN] Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes. May be involved in mediating central nervous system effects of therapeutic agents ranging from antidepressants to antiasthmatic and anti-inflammatory agents.<ref>PMID:10846163</ref> <ref>PMID:15003452</ref> | |||
==See Also== | |||
*[[Phosphodiesterase 3D structures|Phosphodiesterase 3D structures]] | |||
== References == | |||
[[Category: | <references/> | ||
[[Category: Armani | __TOC__ | ||
[[Category: Carzaniga | </StructureSection> | ||
[[Category: Rizzi | [[Category: Homo sapiens]] | ||
[[Category: Large Structures]] | |||
[[Category: Armani E]] | |||
[[Category: Carzaniga L]] | |||
[[Category: Rizzi A]] |
Latest revision as of 10:27, 1 May 2024
Human phosphodiesterase 4B catalytic domain in complex with a pyrrolidinyl inhibitor.Human phosphodiesterase 4B catalytic domain in complex with a pyrrolidinyl inhibitor.
Structural highlights
FunctionPDE4B_HUMAN Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes. May be involved in mediating central nervous system effects of therapeutic agents ranging from antidepressants to antiasthmatic and anti-inflammatory agents.[1] [2] See AlsoReferences
|
|